Suppr超能文献

秋水仙碱对肝脏α1-肾上腺素能受体反应性的调节:游离胞质钙离子依赖性和非依赖性反应的解离

Modulation of the hepatic alpha 1-adrenoceptor responsiveness by colchicine: dissociation of free cytosolic Ca(2+)-dependent and independent responses.

作者信息

Butta N, Martin-Requero A, Urcelay E, Parrilla R, Ayuso M S

机构信息

Department of Human Pathology and Molecular Genetics, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.

出版信息

Br J Pharmacol. 1996 Aug;118(7):1797-805. doi: 10.1111/j.1476-5381.1996.tb15606.x.

Abstract
  1. The cytoskeletal depolymerizing agent, colchicine, prevents the hepatic alpha 1-adrenoceptor-mediated stimulation of respiration, H+ and Ca2+ release to the effluent perfusate, intracellular alkalosis, and glycogenolysis. Unlike the other parameters, colchicine does not perturb the alpha 1-agonist-induced stimulation of gluconeogenesis or phosphorylase 'a' activation, and enhances the increase in portal pressure response. The lack of effect of colchicine on the hepatic alpha 2-adrenoceptor-mediated effects indicates that its actions are alpha 1-specific. 2. Colchicine enhances the acute alpha 1-adrenoceptor-mediated intracellular Ca2+ mobilization and prevents the activation of protein kinase C. This differential effect on the two branches of the alpha 1-adrenoceptor signalling pathway is a distinctive feature of the colchicine action. 3. The lack of effect of colchicine in altering the alpha 1-adrenoceptor ligand binding affinity suggests that it might interact with some receptor-coupled regulatory element(s). 4. The acuteness of the colchicine effect and the ability of its isomer beta-lumicolchicine to prevent all the alpha 1-adrenoceptor-mediated responses but the increase in vascular resistance, indicate that its action cannot be merely ascribed to its effects in depolymerizing tubulin. 5. Colchicine perturbs the hepatic responses to vasoactive peptides. It enhances the vasopressin-induced rise of cytosolic free Ca2+ in isolated hepatocytes and prevents the sustained decrease of Ca2+ in the effluent perfusate. It also inhibits the stimulation of glycogenolysis, without altering the stimulation of gluconeogenesis. 6. It is concluded that there are at least two major alpha 1-adrenoceptor signalling pathways. One is colchicine-sensitive, independent of variations in free cytosolic Ca2+, and protein kinase C-dependent; the other one is colchicine-insensitive, dependent on variations in free cytosolic Ca2+, and protein kinase C-independent.
摘要
  1. 细胞骨架解聚剂秋水仙碱可阻止肝脏α1 - 肾上腺素能受体介导的呼吸刺激、H⁺和Ca²⁺释放到流出的灌注液中、细胞内碱中毒以及糖原分解。与其他参数不同,秋水仙碱不会干扰α1 - 激动剂诱导的糖异生刺激或磷酸化酶“a”的激活,反而会增强门静脉压力反应的增加。秋水仙碱对肝脏α2 - 肾上腺素能受体介导的效应无影响,表明其作用具有α1特异性。2. 秋水仙碱增强急性α1 - 肾上腺素能受体介导的细胞内Ca²⁺动员,并阻止蛋白激酶C的激活。秋水仙碱对α1 - 肾上腺素能受体信号通路两个分支的这种差异效应是其作用的一个显著特征。3. 秋水仙碱在改变α1 - 肾上腺素能受体配体结合亲和力方面无作用,这表明它可能与某些受体偶联调节元件相互作用。4. 秋水仙碱效应的急性程度及其异构体β - 光秋水仙碱阻止所有α1 - 肾上腺素能受体介导的反应(但不包括血管阻力增加)的能力,表明其作用不能仅仅归因于其使微管蛋白解聚的效应。5. 秋水仙碱扰乱肝脏对血管活性肽的反应。它增强了血管加压素诱导的离体肝细胞胞质游离Ca²⁺升高,并阻止流出灌注液中Ca²⁺的持续降低。它还抑制糖原分解的刺激,而不改变糖异生的刺激。6. 得出的结论是,至少有两条主要的α1 - 肾上腺素能受体信号通路。一条对秋水仙碱敏感,独立于胞质游离Ca²⁺的变化,且依赖于蛋白激酶C;另一条对秋水仙碱不敏感,依赖于胞质游离Ca²⁺的变化,且不依赖于蛋白激酶C。

相似文献

8
Characterization of the alpha 1-adrenoceptor-mediated responses in perfused rat liver.
Biochim Biophys Acta. 1993 Dec 16;1220(1):49-56. doi: 10.1016/0167-4889(93)90096-8.

本文引用的文献

2
Inositol trisphosphate and calcium signalling.肌醇三磷酸与钙信号传导
Nature. 1993 Jan 28;361(6410):315-25. doi: 10.1038/361315a0.
4
Characterization of the alpha 1-adrenoceptor-mediated responses in perfused rat liver.
Biochim Biophys Acta. 1993 Dec 16;1220(1):49-56. doi: 10.1016/0167-4889(93)90096-8.
7

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验